Brief: SELLAS Life Sciences Group Announces $20 Mln Registered Direct Offering And Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
15/03/2024 13:10
March 15 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS LIFE SCIENCES GROUP ANNOUNCES $20 MILLION
REGISTERED
DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED
AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNXDCXBs
Further company coverage: SLS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses